Kewaunee Scientific (KEQU) Competitors

Kewaunee Scientific logo
$35.22 -0.48 (-1.35%)
Closing price 11/16/2026 03:58 PM Eastern
Extended Trading
$35.22 +0.00 (+0.00%)
As of 11/16/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KEQU vs. SSII, OBIO, CV, OFIX, and TMCI

Should you buy Kewaunee Scientific stock or one of its competitors? Kewaunee Scientific's main competitors and comparable companies include SS Innovations International (SSII), Orchestra BioMed (OBIO), CapsoVision (CV), Orthofix Medical (OFIX), and Treace Medical Concepts (TMCI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kewaunee Scientific compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 418.52%. Given SS Innovations International's higher probable upside, research analysts clearly believe SS Innovations International is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

SS Innovations International has a beta of -1.52, meaning that its stock price is 252% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

Kewaunee Scientific has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M6.37-$12.13M-$0.06N/A
Kewaunee Scientific$282M0.36$9.62M$2.7612.76

In the previous week, SS Innovations International had 5 more articles in the media than Kewaunee Scientific. MarketBeat recorded 6 mentions for SS Innovations International and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat SS Innovations International's score of 0.52 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
SS Innovations International Positive
Kewaunee Scientific Very Positive

Kewaunee Scientific has a net margin of 2.97% compared to SS Innovations International's net margin of -23.73%. Kewaunee Scientific's return on equity of 11.61% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
Kewaunee Scientific 2.97%11.61%4.82%

32.7% of Kewaunee Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Kewaunee Scientific beats SS Innovations International on 11 of the 14 factors compared between the two stocks.

How does Kewaunee Scientific compare to Orchestra BioMed?

Kewaunee Scientific (NASDAQ:KEQU) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 7.5% of Orchestra BioMed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Orchestra BioMed had 10 more articles in the media than Kewaunee Scientific. MarketBeat recorded 11 mentions for Orchestra BioMed and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat Orchestra BioMed's score of 1.10 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company Overall Sentiment
Kewaunee Scientific Very Positive
Orchestra BioMed Positive

Kewaunee Scientific has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Orchestra BioMed has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Kewaunee Scientific has a net margin of 2.97% compared to Orchestra BioMed's net margin of -182.50%. Kewaunee Scientific's return on equity of 11.61% beat Orchestra BioMed's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.61% 4.82%
Orchestra BioMed -182.50%-186.93%-51.90%

Orchestra BioMed has a consensus target price of $13.29, suggesting a potential upside of 86.60%. Given Orchestra BioMed's stronger consensus rating and higher possible upside, analysts plainly believe Orchestra BioMed is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Orchestra BioMed
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Kewaunee Scientific has higher revenue and earnings than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.36$9.62M$2.7612.76
Orchestra BioMed$33.48M13.07-$52.70M-$0.75N/A

Summary

Kewaunee Scientific beats Orchestra BioMed on 9 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Kewaunee Scientific has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CapsoVision$13.55M23.90-$25.32M-$0.47N/A
Kewaunee Scientific$282M0.36$9.62M$2.7612.76

Kewaunee Scientific has a net margin of 2.97% compared to CapsoVision's net margin of -210.09%. Kewaunee Scientific's return on equity of 11.61% beat CapsoVision's return on equity.

Company Net Margins Return on Equity Return on Assets
CapsoVision-210.09% -188.10% -139.99%
Kewaunee Scientific 2.97%11.61%4.82%

CapsoVision currently has a consensus target price of $9.50, suggesting a potential upside of 46.83%. Given CapsoVision's stronger consensus rating and higher possible upside, research analysts clearly believe CapsoVision is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CapsoVision
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

CapsoVision has a beta of -2.34, meaning that its stock price is 334% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

32.7% of Kewaunee Scientific shares are held by institutional investors. 2.3% of CapsoVision shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, CapsoVision had 11 more articles in the media than Kewaunee Scientific. MarketBeat recorded 12 mentions for CapsoVision and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat CapsoVision's score of 0.58 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
CapsoVision Positive
Kewaunee Scientific Very Positive

Summary

Kewaunee Scientific beats CapsoVision on 10 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Orthofix Medical?

Kewaunee Scientific (NASDAQ:KEQU) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Orthofix Medical had 7 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for Orthofix Medical and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat Orthofix Medical's score of 0.63 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company Overall Sentiment
Kewaunee Scientific Very Positive
Orthofix Medical Positive

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 2.7% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kewaunee Scientific has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

Orthofix Medical has a consensus target price of $13.50, indicating a potential upside of 98.53%. Given Orthofix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Kewaunee Scientific has a net margin of 2.97% compared to Orthofix Medical's net margin of -5.39%. Kewaunee Scientific's return on equity of 11.61% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.61% 4.82%
Orthofix Medical -5.39%-10.32%-5.19%

Kewaunee Scientific has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.36$9.62M$2.7612.76
Orthofix Medical$822.31M0.34-$92.19M-$1.12N/A

Summary

Kewaunee Scientific beats Orthofix Medical on 10 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Kewaunee Scientific has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$212.69M1.36-$59M-$0.86N/A
Kewaunee Scientific$282M0.36$9.62M$2.7612.76

In the previous week, Treace Medical Concepts had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Treace Medical Concepts and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat Treace Medical Concepts' score of 0.76 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Treace Medical Concepts Positive
Kewaunee Scientific Very Positive

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Treace Medical Concepts currently has a consensus price target of $6.17, suggesting a potential upside of 39.52%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Treace Medical Concepts has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Kewaunee Scientific has a net margin of 2.97% compared to Treace Medical Concepts' net margin of -27.44%. Kewaunee Scientific's return on equity of 11.61% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-27.44% -72.99% -29.19%
Kewaunee Scientific 2.97%11.61%4.82%

Summary

Treace Medical Concepts and Kewaunee Scientific tied by winning 8 of the 16 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KEQU vs. The Competition

MetricKewaunee ScientificHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$104.06M$5.96B$7.83B$12.17B
Dividend YieldN/A1.69%2.46%4.42%
P/E Ratio12.3536.3133.7827.89
Price / Sales0.365.448.585.72
Price / Cash6.0323.9521.9322.50
Price / Book1.314.374.403.70
Net Income$9.62M$143.12M$3.52B$392.17M
7 Day Performance4.79%-3.80%-4.48%-3.37%
1 Month Performance8.63%-2.84%-3.53%-5.82%
1 Year Performance-10.88%0.21%0.12%-6.24%

Kewaunee Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KEQU
Kewaunee Scientific
1.098 of 5 stars
$35.22
-1.3%
N/A-12.9%$104.06M$282M12.351,231
SSII
SS Innovations International
1.97 of 5 stars
$1.61
-13.9%
$7.00
+334.8%
-78.3%$374.72M$42.49MN/A483
OBIO
Orchestra BioMed
4.1674 of 5 stars
$5.73
+0.5%
$13.17
+129.8%
+80.7%$350.28M$33.48MN/A86
CV
CapsoVision
3.6721 of 5 stars
$6.37
-1.1%
$9.50
+49.1%
+26.4%$322.30M$13.89MN/A99
OFIX
Orthofix Medical
3.9101 of 5 stars
$7.12
-9.9%
$14.75
+107.2%
-54.5%$321.79M$822.31MN/A1,605

Related Companies and Tools


This page (NASDAQ:KEQU) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners